RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …

Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract
disease in children< 2 years of age. Increased morbidity and mortality have been reported in …

Rapid and sensitive pathogen detection is important for prevention and control of disease.
Here, we report a label-free diagnostic platform that combines surface-enhanced Raman …

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease
in young children and a substantial contributor to respiratory tract disease throughout life …

Since the first human respiratory syncytial virus (HRSV) genotype classification in 1998,
inconsistent conclusions have been drawn regarding the criteria that define HRSV …

Abstract N 6-methyladenosine (m6A) is the most prevalent internal modification of mRNAs in
most eukaryotes. Here we show that RNAs of human respiratory syncytial virus (RSV) are …

Respiratory syncytial virus (RSV) is a major cause of serious lower respiratory tract
infections in children< 5 years of age worldwide and repeated infections throughout life …

Respiratory syncytial virus (RSV) is a top cause of severe lower respiratory tract disease and
mortality in young children and the elderly. The viral envelope G glycoprotein contributes to …

Highlights•Immunological goals for vaccination depend on whether it is for primary induction
or boosting of pre-existing immunity.•Boosting neutralizing activity is the major goal for …

Respiratory syncytial virus (RSV) infection can cause bronchiolitis, pneumonia, morbidity,
and some mortality, primarily in infants and the elderly, for which no vaccine is available …